Biogenesis Bagó was chosen by Canada as one of the vaccine laboratories for its foot-and-mouth disease vaccine bank

Published Jun 11, 2025

Original content

The Biogénesis Bagó laboratory scored a new victory this week, after Canada announced that it was selected as one of the suppliers for its foot-and-mouth disease vaccine bank, a disease from which it has been free since 1952. The news was disclosed by the Canadian Food Inspection Agency (CFIA), which indicated that the Public Services and Procurement portfolio awarded contracts to the Argentine multinational and the Boehringer Ingelheim Animal Health laboratory from Germany, after a "competitive, open, fair, and transparent" bidding process. It is worth remembering that Biogénesis is a provider of the antigen bank for Argentina, as well as for the United States since 2006. "Preparedness initiatives, including the creation of a Canadian foot-and-mouth disease vaccine bank, are fundamental to protecting Canadian animals and agriculture. Having an immediate supply of emergency foot-and-mouth disease vaccines will strengthen our ability to respond effectively to an outbreak if it ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.